Federal contract award
W81K0223P0114
BIOMERIEUX VARIOUS TESTING KITS & REAGENTS FOR USE WITH GOVERNMENT-OWNED ANALYZERS USE OF VITEK MS PRIME ANALYZER, INCLUDING SERVICE AGREEMENTS. BASE PERIOD: 1 OCT 2023 - 30 SEP 2024
Award details
Obligations, current value and potential value describe different measures; they are never added together.
| Field | Reported value |
|---|---|
| Agency | Department of Defense |
| Office | DEFENSE HEALTH AGENCY HCD WEST |
| NAICS | 325413 — In-Vitro Diagnostic Substance Manufacturing |
| PSC | 6550 — In Vitro Diagnostic Substances, Reagents, Test Kits and Sets |
| Parent award / vehicle | Not reported |
| Set-aside | NO SET ASIDE USED. |
| Pricing type | FIRM FIXED PRICE |
| Obligations | $654.3K |
| Current contract value | $654.3K |
| Potential contract value / ceiling | $1.3M |
| Start date | Oct 1, 2023 |
| Current end date | Sep 30, 2024 |
| Potential end date | Sep 30, 2028 |
| Latest award activity | Apr 9, 2026 |
| Source loaded | Sep 19, 2026 |
Funding and modification history
Showing the latest 8 of 8 loaded transactions. Negative values are deobligations.
| Date | Modification | Obligation change | Description |
|---|---|---|---|
| Apr 9, 2026 | P00013 | $0 | BIOMERIUEX VARIOUS TESTING KITS AND REAGENTS FOR USE WITH GOVERNMENT-OWNED ANALYZERS; USE OF VITEK MS PRIME ANALYZER, INCLUDING SERVICE AGREEMENTS FOR ANALYZERS FOR DEPT OF PATHOLOGY, TAMC. |
| Apr 2, 2026 | P00012 | $0 | BIOMERIUEX VARIOUS TESTING KITS AND REAGENTS FOR USE WITH GOVERNMENT-OWNED ANALYZERS; USE OF VITEK MS PRIME ANALYZER, INCLUDING SERVICE AGREEMENTS FOR ANALYZERS FOR DEPT OF PATHOLOGY, TAMC. |
| Mar 26, 2026 | P00011 | $0 | BIOMERIUEX VARIOUS TESTING KITS AND REAGENTS FOR USE WITH GOVERNMENT-OWNED ANALYZERS; USE OF VITEK MS PRIME ANALYZER, INCLUDING SERVICE AGREEMENTS FOR ANALYZERS FOR DEPT OF PATHOLOGY, TAMC. |
| Dec 3, 2025 | P00010 | $302.6K | BIOMERIUEX VARIOUS TESTING KITS AND REAGENTS FOR USE WITH GOVERNMENT-OWNED ANALYZERS; USE OF VITEK MS PRIME ANALYZER, INCLUDING SERVICE AGREEMENTS FOR ANALYZERS FOR DEPT OF PATHOLOGY, TAMC. |
| Dec 2, 2025 | P00009 | $-131.6K | BIOMERIUEX VARIOUS TESTING KITS AND REAGENTS FOR USE WITH GOVERNMENT-OWNED ANALYZERS; USE OF VITEK MS PRIME ANALYZER, INCLUDING SERVICE AGREEMENTS FOR ANALYZERS FOR DEPT OF PATHOLOGY, TAMC. |
| Jul 17, 2025 | P00008 | $0 | BIOMERIEUX VARIOUS TESTING KITS AND REAGENTS FOR USE WITH GOVERNMENT OWNED ANALYZERS USE OF VITEK MS PRIME ANALYZER, INCLUDING SERVICE AGREEMENTS FOR ANALYZERS FOR DEPT OF PATHOLOGY |
| Jan 29, 2025 | P00007 | $0 | BIOMERIEUX VARIOUS TESTING KITS & REAGENTS FOR USE WITH GOVT-OWNED ANALYZERS, USE OF VITEK MS ANALYZER, INCLUDING SERVICE AGREEMENTS. MOD P00007: DELETE OBSOLETE ITEMS AND ADD NEW CAP APPROVED ITEMS. |
| Oct 22, 2024 | P00006 | $302.6K | BIOMERIEUX VARIOUS TESTING KITS & REAGENTS FOR USE WITH GOVT-OWNED ANALYZERS, USER OF VITEK MS ANALYZER, INCLUDING SERVICE AGREEMENTS. MOD P00006: INCORPORATE FY25 FUNDS AND ACWS TRANSITION INFORMATION. |
Estimated positioning window
Sep 30, 2027 – Mar 30, 2028
70/100
Why this recompete signal
Contract timing and recorded acquisition signals at the time of calculation.
Stored score: 70/100. Available recorded signals: 65 points.
- Contract end 2028-09-30 (699 days from calculation)
- +25 points
- 93 historical awards in this buyer and category group
- +15 points
- 8 recorded award transactions
- +10 points
- Latest award action: 2026-04-09
- +5 points
- Parent award identifier recorded
- +0 points
- Solicitation identifier recorded
- +10 points
- Linked official forecast
- +0 points
- Calculated on
- 2026-11-01 10:17:53.997580+00:00
The historical group combines buyer, NAICS, and PSC. Multiple awards in this group do not by themselves establish repeated competitions.
Rule-based research score; it does not measure your chance of winning.
This older calculation does not retain a complete reproducible breakdown. Missing or changed inputs are not assigned invented points: Original award-value bonus input.
Recompete score calculated Nov 1, 2026.
Research next steps
- Check the linked forecast or SAM for a confirmed solicitation and current timing.
- Verify whether remaining options may extend performance beyond the current end date.
- Check the stated set-aside against the solicitation and current certifications.
- Review the award scope and buyer evidence before making a bid/no-bid decision.